Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Hanover Media Strategy Limited .
Filed returns
302
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2022 | Hanover Media Strategy Limited | Economic Development and Industry | Request for meetings with the Minister of State for Trade Promotion and Digital Transformation, the Minister of State for European Affairs, and the Assistant Secretary for EU and Digital Policy. (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Economic Development and Industry | Request for a meeting with the Minister of State for Trade Promotion, Digital and Company Regulation. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Energy and Natural Resources | Ocean Winds' offshore wind projects in Ireland (Zoning or development) | 10 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Transport | Sharing pre-Budget submission ahead of Budget 2023 (Public policy or programme) | 20 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Transport | To highlight the disruption caused to car rental operators as a result of NCT delays (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Transport | The impact of vehicle supply shortages on the car rental sector (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Transport | Request for a meeting with local authorities to discuss shared sustainable mobility solutions. (Matters involving public funds) | 7 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Health | Rare Disease Policy (Legislation) | 9 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Transport | Discussion on sustainable mobility policy with Department of Transport and stakeholders (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Health | Briefing on AstraZeneca's operations in Ireland. (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Health | Visit to the Alexion, AstraZeneca Rare Disease facility in Athlone. (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Health | Meeting to discuss the reimbursement landscape and access challenges for personalised medicines in Ireland. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Transport | Invitation to attend the launch of MPI and to participate in a discussion on transport policy. (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Economic Development and Industry | Request for a meeting to introduce Uber's operations in Ireland. (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Transport | Request for a meeting with local authorities to discuss shared sustainable mobility solutions. (Matters involving public funds) | 59 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Transport | Shared Pre-Budget 2023 submission to inform policy on shared transport, electrification and vehicle supply (Public policy or programme) | 29 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Transport | To request a meeting to highlight lack of supply of vehicles for car rental and leasing customers as well as delays with NCT processing (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Energy and Natural Resources | Ocean Winds' offshore wind projects in Ireland (Zoning or development) | 62 | On lobbying.ie |
| Jan–Apr 2022 | Hanover Media Strategy Limited | Health | Introducing Horizon and its presence in Ireland (Public policy or programme) | 16 | On lobbying.ie |
| Jan–Apr 2022 | Hanover Media Strategy Limited | Health | Update on AstraZeneca sponsored roundtable outcomes held for Chronic Obstructive Pulmonary Disease (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2022 | Hanover Media Strategy Limited | Communications | To share a briefing on the Communications Regulation (Enforcement) Bill 2022 (Legislation) | 13 | On lobbying.ie |
| Sep–Dec 2021 | Hanover Media Strategy Limited | Health | Partnership for Health System Sustainability and Resilience (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2021 | Hanover Media Strategy Limited | Transport | Sustainable Mobility Policy (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 4 | On lobbying.ie |
| Sep–Dec 2021 | Hanover Media Strategy Limited | Health | Update on AstraZeneca COVID-19 vaccine and therapies (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Update on COVID-19 Vaccine AstraZeneca (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 9 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Finance | Cost of Motor Insurance Policies in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Transport | Building a safe, sustainable e-scooter market in Ireland (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Medicines Access for Irish patients with rare diseases (Legislation) | 1 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Finance | Consumer protection for SMEs whose loans have been sold to unregulated entities (Legislation) | 12 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Update on COVID-19 Vaccine AstraZeneca (Public policy or programme) | 15 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 15 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Finance | Cost of Motor Insurance Policies in Ireland (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Environment | Sustainability commitments by Takeda (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Economic Development and Industry | To discuss the lifting of COVID-related construction restrictions. (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Trade | To communicate with Government about the operation of new automated customs procedures. (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 9 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Finance | The impact of Covid-19 on the car rental industry (Public policy or programme) | 20 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Engagement on National Screening Advisory Committee Bill 2020 and the newborn screening programme (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Centralised Services for Rare Disease Medicines (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 14 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Transport | Cost of Motor Insurance Policies in Ireland (Public policy or programme) | 85 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Provided update to select politicians on developments in Oncology therapies and barriers to access (Matters involving public funds) | 4 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Briefed select parliamentarians on potential Covid-19 vaccine (Public policy or programme) | 22 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 10 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Health | Update on potential COVID-19 Vaccine (Matters involving public funds) | 4 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Health | The reimbursement process and pathway affecting AstraZeneca medicines (Matters involving public funds) | 10 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 110 | 36.4% | |
| Transport | 98 | 32.5% | |
| Economic Development and Industry | 27 | 8.9% | |
| Energy and Natural Resources | 16 | 5.3% | |
| Finance | 14 | 4.6% | |
| Children and Youth Affairs | 11 | 3.6% | |
| Sports and Recreation | 5 | 1.7% | |
| Environment | 4 | 1.3% | |
| Heritage | 4 | 1.3% | |
| Communications | 3 | 1.0% | |
| EU Affairs | 3 | 1.0% | |
| Housing | 2 | 0.7% | |
| Arts | 1 | 0.3% | |
| Development and Zoning | 1 | 0.3% | |
| Education and Training | 1 | 0.3% | |
| Taxation | 1 | 0.3% | |
| Trade | 1 | 0.3% |